🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety, tolerability and glucose-lowering effica...
Status
Completed
Location
Multiple Locations
Start Date
2006-08-11
Trial ID
NCT02004886
This research will help us to learn if the medicine called metformin reduce...
Status
Recruiting
Location
Phoenix VA Health Care System, Phoenix, AZ
Start Date
2023-04-03
Trial ID
NCT02915198
Treatments Being Tested
This is a multicenter randomized, double-blind, placebo- and active-control...
Status
Terminated
Location
Multiple Locations
Start Date
2015-07-27
Trial ID
NCT02492763
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of omariglip...
Status
Completed
Location
Multiple Locations
Start Date
2013-01-11
Trial ID
NCT01755156
This study will examine the safety and efficacy of the addition of omarigli...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-18
Trial ID
NCT01704261
Treatments Being Tested
The goal of this study was to determine the metabolic mechanism for a certa...
Status
Completed
Location
Mayo Clinic
Start Date
2009-08
Trial ID
NCT00951899
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of al...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT01023581
Treatments Being Tested
This Phase 2a, randomized, double-blind, active-controlled study will evalu...
Status
Not Yet Recruiting
Location
UniSC Clinical Trials
Start Date
2026-09-01
Trial ID
NCT07139405
Treatments Being Tested
The planned study is to determine the safety and pharmacokinetic properties...
Status
Completed
Location
BioResearch Group Sp. z o.o.
Start Date
2020-05-27
Trial ID
NCT04622111
Treatments Being Tested
To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118)...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT01434186
Treatments Being Tested